LBF20207PG48: Difference between revisions
No edit summary |
No edit summary |
||
Line 11: | Line 11: | ||
|Chemical Synthesis= | |Chemical Synthesis= | ||
|Metabolism= | |Metabolism= | ||
|Biological Activity=8-iso PGF2<FONT FACE="Symbol">b</FONT> has been reported to show very weak contraction of human umbilical vein artery and does not promote aggregation of human whole blood.[[Reference:Oliveira_L:Stallwood_NA:Crankshaw_DJ:,Br. J. Pharmacol.,2000,129,509|{{RelationTable/GetFirstAuthor|Reference:Oliveira_L:Stallwood_NA:Crankshaw_DJ:,Br. J. Pharmacol.,2000,129,509}}]][[Reference:Cranshaw_JH:Evans_TW:Mitchell_JA:,Br. J. Pharmacol.,2001,132,1699|{{RelationTable/GetFirstAuthor|Reference:Cranshaw_JH:Evans_TW:Mitchell_JA:,Br. J. Pharmacol.,2001,132,1699}}]] | |||
}} | }} | ||
{{Lipid/Footer}} | {{Lipid/Footer}} |
Revision as of 21:00, 6 January 2010
LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
IDs and Links | |
---|---|
LipidBank | XPR1796 |
LipidMaps | - |
CAS | |
KEGG | {{{KEGG}}} |
KNApSAcK | {{{KNApSAcK}}} |
mol | LBF20207PG48 |
8-iso Prostaglandin F_2β | |
---|---|
Structural Information | |
9b,11a,15S-trihydroxy- (8b) -prosta-5Z,13E-dien-1-oic acid | |
| |
Formula | C20H34O5 |
Exact Mass | 354.240624198 |
Average Mass | 354.48096000000004 |
SMILES | C(CC[C@H](O)C=C[C@H]([C@@H]1CC=CCCCC(O)=O)[C@@H](C[C@H]1O)O)CC |
Physicochemical Information | |
8-iso PGF2b has been reported to show very weak contraction of human umbilical vein artery and does not promote aggregation of human whole blood. Oliveira_L et al. Cranshaw_JH et al. | |
Spectral Information | |
Mass Spectra | |
UV Spectra | |
IR Spectra | |
NMR Spectra | |
Other Spectra | |
Chromatograms |
Reported Metabolites, References | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|